Flavonoids: Prospective Strategy for the Management of Diabetes and Its Associated Complications

Flavonoids: Prospective Strategy for the Management of Diabetes and Its Associated Complications

Vineet Mehta (Jaypee University of Information Technology, India) and Udayabanu Malairaman (Jaypee University of Information Technology, India)
DOI: 10.4018/978-1-4666-9494-1.ch013
OnDemand PDF Download:


Diabetes Mellitus is one of the major healthcare problems faced by the society today and has become alarmingly epidemic in many parts of the world. Despite enormous knowledge and technology advancement, available diabetes therapeutics only provide symptomatic relief by reducing blood glucose level, thereby, just slows down development and progression of diabetes and its associated complications. Thus, the need of the day is to develop alternate strategies that can not only prevent the progression but also reverse already “set-in” diabetic complications. Many flavonoids are reported, traditionally as well as experimentally, to be beneficial in averting diabetes and lowering risk of its accompanying complications. In the present chapter we have convened different flavonoids beneficial in diabetes and comorbid complications and discussed their mechanisms of action. Further, we conclude that coupling current therapeutics with flavonoids might provide exceptional advantage in the management of diabetes and its complications.
Chapter Preview


Diabetes mellitus (DM) is a complex metabolic disorder arising from variety of factors, genetic or environmental, resulting in hyperglycemia. Hyperglycemia leads to acute and chronic metabolic abnormalities, amongst which neuropathy, nephropathy, retinopathy, learning and memory impairment and cardiovascular complications are the major causes of morbidity (Goodman, 2011). Hyperglycemia is a consequence of either pancreatic β-cells destruction, thereby decreasing the level of insulin secretion (Type-1 Diabetes Mellitus; T1DM) or due to decreased responsiveness of target cells towards insulin with or without insulin secretory defects (Type-2 Diabetes Mellitus; T2DM) (American Diabetes Association, 2013). In 2013, 382 million people across the globe were reported to be diabetic amongst which 5.1 million lost their lives and therapeutic management of diabetes costs $548 billion. By the year 2035, diabetic population of the world is projected to increase by 55% and its management cost is expected to reach $627 billion. Major concern is that 46% cases of DM remain undiagnosed for longtime (International Diabetes Federation, 2013) and by the time clinical symptoms appear, damage has already been done. Majority of current diabetic research is focused on identifying various therapeutic targets with protective as well as restorative ability to reverse the diabetic damage. Currently available antidiabetic medications controls hyperglycemia by reducing dietary glucose absorption, disposing blood glucose into muscles, liver or adipose tissue and by increasing its excretion form the body thereby providing only symptomatic relief. None of the available treatments are capable of reversing the damage inflicted by diabetes and ceasing its progression (Tripathi, 2013; Verma, Itankar, & Arora, 2013). Hyperglycemia in diabetes generates excessive reactive oxygen/nitrogen species (ROS/RNS) by oxidation of glucose. These highly reactive ROS/RNS binds and disturb normal functioning of biomolecules such as proteins, ribonucleic acid (RNA), deoxy-ribonucleic acid (DNA), etc. and thus, directly or indirectly aids in the development of various diabetic complications (Rochette, Zeller, Cottin, & Vergely, 2014).Thus the use of flavonoids, which are natural antioxidants, may provide additional advantage over current antidiabetic therapy. Present chapter discusses various targets that are currently used for the management of DM and potential of various flavonoids to exploit them. It also provides the list of flavonoids that were reported to be effective in managing diabetes or diabetic complications with their possible mechanisms, which needs further exploration to fully understand their antidiabetic potential.

All the therapeutic interventions currently used clinically for the management of DM exploit primarily following biochemical processes of human body.

Key Terms in this Chapter

Diabetic Complications: Complications in the biological system that arise secondary to long standing diabetes are known as diabetic complications. They include neuropathy, nephropathy, retinopathy, etc.

Aldose Reductase: Aldose reductase is an oxidoreductase enzyme responsible for catalyzing biochemical reaction that leads to detoxification of aldehydes and carbohydrates, especially glucose.

Type 2 Diabetes Mellitus: The most common type of diabetes, characterized by insulin resistance leading to hyperglycemia. Thus it is also known as non-insulin-dependent diabetes.

Insulin: Insulin is a 51 amino acid peptide hormone produced in the ß-cells of pancreas. It is responsible for maintaining normal blood glucose level in the body.

Antioxidant: Substance that inhibits oxidation is referred to as antioxidant. In biological system, any substance which either directly inhibits oxidative stress or indirectly facilitates regeneration or formation of antioxidant enzymes is referred to as antioxidant.

Herbal Therapy: Whole plant or its any part or extract or other such preparations or isolated compound or mixture of these when used for preventing or curing any disease or disease condition, such therapy is referred to as herbal therapy.

Flavonoids: Flavonoids are 15 carbon polyphenolic secondary metabolites of plants having two aromatic rings linked by a 3 carbon bridge i.e. C6-C3-C6 linkage. Flavonoids are mainly responsible for antioxidant property of the plants.

Complete Chapter List

Search this Book: